ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05033	Nicotine addiction	17/224	56/7206	4.31590622652e-13
ko04744	Phototransduction	13/224	36/7206	2.19654555767e-11
ko04727	GABAergic synapse	20/224	110/7206	1.12566181736e-10
ko04721	Synaptic vesicle cycle	17/224	80/7206	2.30327862932e-10
ko04723	Retrograde endocannabinoid signaling	24/224	175/7206	6.56115004229e-10
ko05032	Morphine addiction	19/224	110/7206	8.39715183608e-10
ko04724	Glutamatergic synapse	18/224	152/7206	9.45891490513e-07
ko04728	Dopaminergic synapse	20/224	185/7206	1.00916975053e-06
ko04725	Cholinergic synapse	16/224	160/7206	3.3879839622e-05
ko04514	Cell adhesion molecules (CAMs)	12/224	130/7206	0.000686120374019
ko04911	Insulin secretion	11/224	117/7206	0.000980816938528
ko04713	Circadian entrainment	12/224	136/7206	0.00102509500201
ko04024	cAMP signaling pathway	19/224	279/7206	0.00116797989487
ko05030	Cocaine addiction	8/224	73/7206	0.00181478462119
ko04726	Serotonergic synapse	11/224	137/7206	0.00347975409552
ko05205	Proteoglycans in cancer	1/224	271/7206	0.00349863183324
ko04391	Hippo signaling pathway - fly	8/224	90/7206	0.00667399540984
ko04010	MAPK signaling pathway	19/224	321/7206	0.00727715210104
ko04080	Neuroactive ligand-receptor interaction	23/224	423/7206	0.00850164144404
ko05166	HTLV-I infection	2/224	292/7206	0.00891839119879
ko05016	Huntington's disease	1/224	215/7206	0.0151969402775
ko05169	Epstein-Barr virus infection	1/224	206/7206	0.0223644132413
ko04930	Type II diabetes mellitus	5/224	54/7206	0.0255174643146
ko04742	Taste transduction	5/224	61/7206	0.0403897366598
ko04210	Apoptosis	1/224	180/7206	0.046244254432
ko04130	SNARE interactions in vesicular transport	4/224	44/7206	0.0468152604999
ko04932	Non-alcoholic fatty liver disease (NAFLD)	1/224	182/7206	0.0468766916595
ko04150	mTOR signaling pathway	1/224	184/7206	0.0476652451083
ko04141	Protein processing in endoplasmic reticulum	1/224	184/7206	0.0476652451083